A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia

Neurogastroenterology and Motility

Volumn 21, Issue 6, 2009, Pages

  Tack, J ^a   Van Den Elzen, B ^b   Tytgat, G ^b   Wajs, E ^c   Van Nueten, L ^c   De Ridder, F ^c   Boeckxstaens, G ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

5 HT 1A agonist; Functional dyspepsia; Gastric accommodation; Visceral sensitivity

Indexed keywords

PLACEBO; R 137696; SEROTONIN 1 AGONIST; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BAROSTAT; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATIETY; SCORING SYSTEM; SIDE EFFECT; STATISTICAL ANALYSIS; STOMACH EMPTYING; SYMPTOMATOLOGY;

ADULT; CYTOCHROME P-450 CYP2D6; DATA INTERPRETATION, STATISTICAL; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPEPSIA; FEMALE; GASTRIC EMPTYING; GASTRIC FUNDUS; GASTROINTESTINAL MOTILITY; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; STOMACH;

EID: 65949096316     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01260.x     Document Type: Article

References (31)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada J-R, Tytgat GJN. Functional gastroduodenal disorders. Gut 1999 45 (Suppl. II 37 42. (Pubitemid 29434811)
2. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004 127 : 1239 55. (Pubitemid 39345892)
3. Stanghellini V, Tosetti C, Paternico A et al. Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999 94 : 2080 5. (Pubitemid 29374535)
4. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003 98 : 783 8. (Pubitemid 36576302)
5. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998 115 : 1346 52. (Pubitemid 28545984)
6. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology 2001 121 : 526 35. (Pubitemid 32822566)
7. Simren M, Vos R, Janssens J, Tack J. Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms. Am J Gastroenterol 2003 98 : 2169 75. (Pubitemid 37305354)
8. Talley NJ. Review article: functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995 9 : 107 15.
9. Tack J, Caenepeel P, Corsetti M, Janssens J. Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004 127 : 1058 66. (Pubitemid 39345875)
10. Boeckxstaens GE, Tytgat GN, Wajs E et al. The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol Motil 2006 18 : 919 26. (Pubitemid 44358862)
11. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999 116 : 573 85. (Pubitemid 29106765)
12. Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000 46 : 468 73. (Pubitemid 30305809)
13. Tack J, Piessevaux H, Coulie B, Fischler B, De Gucht V, Janssens J. A placebo-controlled trial of buspirone, a fundus relaxing drug in functional dyspepsia: effect on symptoms and gastric sensory motor function (abstr). Gastroenterology 1999 116 : A325.
14. Notivol R, Coffin B, Azpiroz F, Mearin F, Serra J, Malagelada JR. Gastric tone determines the sensitivity of the stomach to distention. Gastroenterology 1995 108 : 330 6.
15. Piessevaux H, Tack J, Wilmer A, Coulie B, Geubel A, Janssens J. Perception of changes in wall tension of the proximal stomach in humans. Gut 2001 49 : 203 8. (Pubitemid 32675112)
16. Caldarella MP, Azpiroz F, Malagelada JR. Antro-fundic dysfunctions in functional dyspepsia. Gastroenterology 2003 124 : 1220 9. (Pubitemid 36531798)
17. Boeckxstaens GE, Hirsch DP, Kuiken SD, Heisterkamp SH, Tytgat GN. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002 97 : 40 8. (Pubitemid 34059762)
18. Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 1999 276 (2 part 1 G373 7. (Pubitemid 29104150)
19. De Ponti F, Crema F, Moro E, Nardelli G, Frigo G, Crema A. Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists. Am J Physiol Gastrointest Liver Physiol 2003 285 : G96 104. (Pubitemid 36736393)
20. Janssen P, Tack J, Sifrim D, Meulemans AL, Lefebvre RA. Influence of 5-HT1 receptor agonists on feline stomach relaxation. Eur J Pharmacol 2004 492 : 259 67. (Pubitemid 38721380)
21. Coulie B, Tack J, Maes B, Geypens B, De Roo M, Janssens J. Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans. Am J Physiol 1997 272 (4 part 1 G902 8. (Pubitemid 27216541)
22. Sarnelli G, Sifrim D, Janssens J, Tack J. Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2004 287 : G988 92. (Pubitemid 39423690)
23. Revicki DA, Rentz AM, Tack J et al. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol 2004 2 : 769 77. (Pubitemid 39200715)
24. Mearin F, Balboa A, Zarate N, Cucala M, Malagelada JR. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 1999 94 : 116 25. (Pubitemid 29063454)
25. Sarnelli G, Vos R, Cuomo R, Janssens J, Tack J. Reproducibility of gastric barostat studies in healthy controls and in dyspeptic patients. Am J Gastroenterol 2001 96 : 1047 53. (Pubitemid 32319135)
26. Dinan TG, Mahmud N, Rathore O et al. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced? Aliment Pharmacol Ther 2001 15 : 1613 8. (Pubitemid 32912404)
27. Raymond JR, Mukhin YV, Gettys TW, Garnovskaya MN. The recombinant 5-HT1A receptor: G protein coupling and signalling pathways. Br J Pharmacol 1999 127 : 1751 64. (Pubitemid 29392868)
28. Chial HJ, Camilleri M, Burton D, Thomfore G, Olden KW, Stephens D. Selective effects of serotonerigic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liever Physiol 2003 284 : G130 7. (Pubitemid 36076258)
29. Talley NJ, Locke GR, Lahr BD et al. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther 2006 23 : 923 36.
30. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006 130 : 1466 79.
31. Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol 2006 41 : 513 23. (Pubitemid 44138192)